Tag: IL-15 superagonist therapy

Home / IL-15 superagonist therapy

Categories

Nogapendekin alfa inbakicept-pmln is approved by the USFDA for BCG-unresponsive non-muscle invasive bladder cancer

Nogapendekin alfa inbakicept-pmln with BCG for bladder cancer There is a type of bladder cancer called NMIBC that does not spread to the muscles. The Food and Drug Administration has approved the use...
il-15-superagonist-therapy

We Are Online! Chat With Us!
Scan the code